UROGEN PHARMA LTD (URGN) — large price moves

Health Care · NASDAQ

Single sessions where URGN closed 10% or more away from the previous close, between 2025-10-08 and 2026-10-08. Each one lists the events filed in the 5 days ending at that session, in date order.

← URGN profile URGN filings Ask about URGN →

Of the 8 moves listed, 5 have at least one filed event in the 5 days ending at the session, and 3 have none. Across the catalog most large moves have nothing filed near them, so an empty list is an ordinary result and not a gap.

Moves

2026-08-05 +16.3% $39.92 to $46.43 filed events in the 5 days to 2026-08-05
- 2026-08-05 Earnings Quarterly results reportedquarter ended 2026-06-30 · reported EPS USD -0.28 against an estimate of USD -0.27 · surprise -5.7%Source: SEC filing calendar + Yahoo earnings history
- 2026-08-05 Periodic filing 10-Q filedaccession 0001437749-26-025794Source: SEC EDGAR
- 2026-08-05 Material event 8-K filed (material event)accession 0001437749-26-025793Source: SEC EDGAR
2026-05-08 +10.6% $26.59 to $29.40 filed events in the 5 days to 2026-05-08
- 2026-05-06 Earnings Quarterly results reportedquarter ended 2026-03-31 · reported EPS USD -0.47 against an estimate of USD -0.48 · surprise +2.6%Source: SEC filing calendar + Yahoo earnings history
- 2026-05-06 Periodic filing 10-Q filedaccession 0001437749-26-015019Source: SEC EDGAR
- 2026-05-06 Material event 8-K filed (material event)accession 0001437749-26-015018Source: SEC EDGAR
- 2026-05-06 Filing language risk_factors changed in the 10-Qsection risk_factors · accession 0001437749-26-015019Source: SEC EDGAR (section comparison against the prior filing)
- 2026-05-06 Filing language mdna changed in the 10-Qsection mdna · accession 0001437749-26-015019Source: SEC EDGAR (section comparison against the prior filing)
- 2026-05-08 Insider trade Open-market sale reported by an insider1 transaction · 1 insider · $300,000Source: SEC Form 4
2026-05-06 +10.2% $23.83 to $26.25 filed events in the 5 days to 2026-05-06
- 2026-05-06 Earnings Quarterly results reportedquarter ended 2026-03-31 · reported EPS USD -0.47 against an estimate of USD -0.48 · surprise +2.6%Source: SEC filing calendar + Yahoo earnings history
- 2026-05-06 Periodic filing 10-Q filedaccession 0001437749-26-015019Source: SEC EDGAR
- 2026-05-06 Material event 8-K filed (material event)accession 0001437749-26-015018Source: SEC EDGAR
- 2026-05-06 Filing language risk_factors changed in the 10-Qsection risk_factors · accession 0001437749-26-015019Source: SEC EDGAR (section comparison against the prior filing)
- 2026-05-06 Filing language mdna changed in the 10-Qsection mdna · accession 0001437749-26-015019Source: SEC EDGAR (section comparison against the prior filing)
2026-04-20 +10.6% $22.54 to $24.92 filed events in the 5 days to 2026-04-20

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2026-04-09 +10.3% $18.61 to $20.53 filed events in the 5 days to 2026-04-09

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2026-03-02 -12.3% $21.70 to $19.02 filed events in the 5 days to 2026-03-02
- 2026-03-02 Earnings Quarterly results reportedquarter ended 2025-12-31 · reported EPS USD -0.53 against an estimate of USD -0.51 · surprise -3.6%Source: SEC filing calendar + Yahoo earnings history
- 2026-03-02 Periodic filing 10-K filedaccession 0001437749-26-006234Source: SEC EDGAR
- 2026-03-02 Material event 8-K filed (material event)accession 0001437749-26-006233Source: SEC EDGAR
2025-12-02 -14.3% $28.46 to $24.38 filed events in the 5 days to 2025-12-02

No filed event was recorded for this company in the 5 days ending on this session. That is what our sources hold, not a statement about what happened.
2025-11-06 +21.9% $19.31 to $23.54 filed events in the 5 days to 2025-11-06
- 2025-11-06 Earnings Quarterly results reportedquarter ended 2025-09-30 · reported EPS USD -0.69 against an estimate of USD -0.68 · surprise -1.1%Source: SEC filing calendar + Yahoo earnings history
- 2025-11-06 Periodic filing 10-Q filedaccession 0001437749-25-033468Source: SEC EDGAR

These are events filed near a session, listed by date. They are not ranked, and no connection between an event and a price move is stated or implied.

Ask the chat about URGN's filings →

See the full company profile: UROGEN PHARMA LTD (URGN).

Informational only — NOT financial advice. Price moves are computed from stored daily closes; filed events come from their own sources with their own dates.